The Structural Disease Center

Filter Your Results




Abiomed Announces Clinical Review Demonstrating Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock

November 14, 2019 -- Abiomed announced the publication of a comprehensive review of cost and comparative effectiveness data for its Impella device. The data is a collection of…

Abiomed Begins Controlled Rollout of Impella 5.5 With SmartAssist in the United States

October 31, 2019 -- Abiomed, Inc. announced that the Impella 5.5 with SmartAssist, a forward flow heart pump, is being introduced in the United States through a controlled rol…

Meeting the Challenge…

Azeem Latib, MD

September/October 2019— As interventional cardiologists, we often learn the most from discussing a case and remembering images of a particular case. Indeed, although guidelines help with the mana…

Massive Thromboembolism, PFO, and Acute Limb Ischemia

Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD

September/October 2019— Video 1. Transthoracic echocardiogram with bubble echocardiography. CASE PRESENTATION A 59-year-old woman presented with worsening dyspnea (1-week d

High-Risk PCI of a Left Main Bifurcation Lesion in a Patient Presenting With Acute Coronary Syndrome and Low LVEF

Moderator: Elvin Kedhi, MD, PhD
Panelists: Renicus Suffridus Hermanides, MD, PhD; Duane Pinto, MD, MPH; and Alejandro Ricalde, MD, FACC

September/October 2019—CASE PRESENTATION A 95-year-old man with a history of chronic atrial fibrillation (for which he was on warfarin), hypertension, hyperlipidemia, gastroesophageal reflux dise…

An Interview With Ulrich Schäfer, MD

September/October 2019—Prof. Schäfer shares updates on the current status of therapies for each of the four heart valves, as well as new technologies to address heart failure and more.

Abiomed Presents Real-World Postapproval Data for Impella RP

October 25, 2019 -- Abiomed, Inc. announced that real-world outcomes data at approximately 2 years show that when physicians followed the FDA’s approved protocol for the…

Corvia Medical's IASD Receives FDA Breakthrough Device Designation for Heart Failure

October 9, 2019 -- Corvia Medical, Inc. announced that the FDA has granted the company a Breakthrough Device designation for its interatrial shunt device (IASD) for heart fail…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.